相关实验视频
Updated: Sep 17, 2025

07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
12.6K
缺氧诱导的HIF-1α/VASN促进了膀癌的进展
Qian-Jin Zhang1, Chun-Hui Liu2, Ke Wang3
1Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, Jiangsu, 223800, China.
Scientific reports
|July 2, 2025
概括
瓦索林 (VASN) 促进膀癌细胞迁移和EMT在低氧状态下,由HIF-1α调节. VASN是膀癌的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 缺氧诱导因子-1α (HIF-1α) 调节了膀癌的缺氧反应.
- 瓦索林 (VASN) 与瘤发展有关,但其在缺氧诱导的膀癌中的作用尚不清楚.
研究的目的:
- 研究VASN在缺氧引起的膀癌中的作用.
- 阐明VASN,HIF-1α和癌细胞行为之间的关系.
主要方法:
- 使用RT4膀癌细胞建立了缺氧模型.
- 通过siRNA和过度表达等离子体操纵HIF-1α和VASN的表达.
- 通过伤口愈合和Transwell测试评估细胞迁移.
- 分析了EMT标记物和信号通路 (YAP/TAZ,PTEN/AKT) 通过西布洛特.
主要成果:
- 在膀癌组织和细胞系中,VASN表达升高.
- 缺氧促进了膀癌细胞迁移和EMT.
- 缺氧增加了RT4细胞中的VASN表达,推动了迁移.
- 在VASN监管的YAP/TAZ和PTEN/AKT路径中.
- HIF-1α与积极相关并激活了VASN表达.
结论:
- 在膀癌中缺氧时,HIF-1α对VASN进行上调.
- VASN促进缺氧诱导的膀癌细胞迁移和EMT.
- VASN代表了膀癌的潜在治疗标.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Mechanism of Angiogenesis
5.9K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.9K
Urinary Bladder
1.5K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
1.5K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K

